Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577420 · ClinicalTrials.gov registry record · NA
Reflexology: An Intervention for Advanced Breast Cancer
A NA study of Breast Cancer, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 451
- Enrollment target
- 12
- Study locations
NCT01577420 is a NA study of Breast Cancer that has completed, run by Michigan State University. The registered enrollment target is 451 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (84% lower). The trial reports 12 study locations across 2 states.
The verdict
NCT01577420, a NA study of Breast Cancer, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 451 participants
- Enrollment target
- 12
- Study locations
Study Summary
The aim of this study is to test a complementary therapy intervention (reflexology) that will assist in improving quality of life (QOL) for women undergoing chemotherapy for late stage (III or IV) breast cancer within the context of conventional medical care. Quality of life will be assessed via intermediate indicators: 1) physical indicators (greater physical functioning, lower presence of symptoms) 2) emotional indicators (greater spirituality, lower anxiety, and lower depressive symptomology); and the outcome indicator of quality of life.
Conditions Studied
Interventions
- OTHER Reflexology Sessions
- OTHER Placebo Sessions
Study Locations (12)
Michigan
- Hurley Medical Center - Flint
- GLCI/McLaren - Flint
- St. Joseph Mercy Oakland Hospital - Grand Rapids
- St. Mary's Health Care Center - Grand Rapids
- Great Lakes Cancer Institute (GLCI) MSU - Lansing
- Sparrow Hospital - Lansing
- William Beaumont Hospital - Royal Oak
- William Beaumont Hospital-Troy Campus - Troy
- St. John Macomb - Warren
- Josephine Ford Cancer Care, Henry Ford Hospital - West Bloomfield
Illinois
- Evanston Northwestern - Evanston
- Mt. Clemens - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2005-08 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01577420
The ClinicalTrials.gov registry entry for NCT01577420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 451 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (84% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Reflexology Sessions is the first listed.
NCT01577420 reports 12 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Illinois.
Frequently Asked Questions
What is clinical trial NCT01577420 about?
NCT01577420 is a clinical study titled "Reflexology: An Intervention for Advanced Breast Cancer". The aim of this study is to test a complementary therapy intervention (reflexology) that will assist in improving quality of life (QOL) for women undergoing chemotherapy for late stage (III or IV) breast cancer within the context of conventional medical care. Quality of life will be assessed via int...
What is the current status of trial NCT01577420?
This trial is currently completed. It is a NA study. The enrollment target is 451 participants. The study started on 2005-08. Estimated completion is 2010-08.
What conditions does trial NCT01577420 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01577420?
The interventions under investigation include: Reflexology Sessions (OTHER), Placebo Sessions (OTHER).
Who is sponsoring clinical trial NCT01577420?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01577420 being conducted?
This trial has 12 study locations across Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.